CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
FarmPharma is developing InterferOx, a therapy for cattle that stimulates the immune system to treat and prevent both viral and bacterial infections. This solution aims to reduce the reliance on antimicrobial drugs in livestock, addressing the growing issue of antimicrobial resistance in agriculture.
The rise of antimicrobial resistance (AMR) is a major threat to global public health as it will cause 10 million deaths per year by 2050.
The rise in AMR is largely driven by the abundant mis- and overuse of antimicrobial drugs in humans and animals.
As such, there is a strong demand to reduce the use of antimicrobials in animals, putting cattle farmers under enormous pressure to change their current way of working.
However, the lack of appropriate alternatives is hindering them to renounce from…
FARMPHARMA AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
